Apricoxib
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Apricoxib, covering 2012-03-15 to 2016-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer [NA]